Dimensional Fund Advisors
ORGO icon

Dimensional Fund Advisors’s Organogenesis Holdings ORGO Stock Holding History

Dimensional Fund Advisors’s Portfolio ORGO Stock Details ORGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.41M Buy
3,050,297
+159,291
+6% +$389K ﹤0.01% 2422
2026
Q1 		$6.85M Buy
2,891,006
+160,026
+6% +$554K ﹤0.01% 2394
2025
Q4 		$14.1M Sell
2,730,980
-178,248
-6% -$864K ﹤0.01% 2148
2025
Q3 		$12.3M Sell
2,909,228
-195,322
-6% -$908K ﹤0.01% 2227
2025
Q2 		$11.4M Buy
3,104,550
+4,154
+0.1% +$15.5K ﹤0.01% 2231
2025
Q1 		$13.4M Buy
3,100,396
+311,131
+11% +$1.26M ﹤0.01% 2127
2024
Q4 		$8.93M Buy
2,789,265
+442,772
+19% +$1.49M ﹤0.01% 2352
2024
Q3 		$6.71M Buy
2,346,493
+309,750
+15% +$869K ﹤0.01% 2428
2024
Q2 		$5.7M Buy
2,036,743
+333,123
+20% +$894K ﹤0.01% 2452
2024
Q1 		$4.84M Buy
1,703,620
+316,480
+23% +$1.08M ﹤0.01% 2560
2023
Q4 		$5.67M Buy
1,387,140
+530,620
+62% +$1.49M ﹤0.01% 2520
2023
Q3 		$2.73M Buy
856,520
+441,173
+106% +$1.4M ﹤0.01% 2689
2023
Q2 		$1.38M Sell
415,347
-40,228
-9% -$119K ﹤0.01% 2866
2023
Q1 		$970K Sell
455,575
-69,642
-13% -$172K ﹤0.01% 2906
2022
Q4 		$1.41K Sell
525,217
-210,230
-29% -$613K ﹤0.01% 2819
2022
Q3 		$2.38M Sell
735,447
-72,739
-9% -$329K ﹤0.01% 2659
2022
Q2 		$3.94M Buy
808,186
+622,589
+335% +$3.83M ﹤0.01% 2518
2022
Q1 		$1.41M Buy
185,597
+5,012
+3% +$38.8K ﹤0.01% 2911
2021
Q4 		$1.67M Buy
180,585
+45,695
+34% +$485K ﹤0.01% 2894
2021
Q3 		$1.92M Buy
+134,890
New +$2.09M ﹤0.01% 2866

Other funds holding ORGO

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Dimensional Fund Advisors's ORGO Position: Q2 2026 in Review

Dimensional Fund Advisors increased its Organogenesis Holdings (ORGO) stake by 5.5% in Q2 2026, buying an estimated $389K and bringing the position to 3,050,297 shares worth $7.41M. The position accounts for ﹤0.01% of the portfolio, ranked #2422.

Dimensional Fund Advisors first reported a position in ORGO in Q3 2021 and has held it in 20 quarters since. The position peaked at $14.1M in Q4 2025. 134 funds tracked by Wall St. Rank hold ORGO as of Q2 2026.

  • Dimensional Fund Advisors held 3,050,297 shares of Organogenesis Holdings worth $7.41M as of Q2 2026.
  • Dimensional Fund Advisors bought 159,291 Organogenesis Holdings shares in Q2 2026, an estimated $389K.
  • Organogenesis Holdings made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q2 2026, its #2422 holding.
  • Dimensional Fund Advisors first reported a position in Organogenesis Holdings in Q3 2021 and has held it in 20 quarters since.
  • Dimensional Fund Advisors's Organogenesis Holdings position peaked at $14.1M in Q4 2025.
  • 134 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q2 2026.

Based on Dimensional Fund Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.